AusperBio to Present Ongoing AHB-137 Clinical Data in Late-Breaking Oral Presentation at AASLD 2024 ...Middle East

PR Newswire - Economy
AusperBio to Present Ongoing AHB-137 Clinical Data in Late-Breaking Oral Presentation at AASLD 2024
SAN FRANCISCO, Oct. 17, 2024 /PRNewswire/ -- AusperBio Therapeutic, Inc. and Ausper Biopharma Co., Ltd. (together AusperBio), a clinical-stage biotechnology company, today announced that new clinical data from its lead candidate AHB-137, an antisense oligonucleotide (ASO) therapeutic,...

Hence then, the article about ausperbio to present ongoing ahb 137 clinical data in late breaking oral presentation at aasld 2024 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AusperBio to Present Ongoing AHB-137 Clinical Data in Late-Breaking Oral Presentation at AASLD 2024 )

Apple Storegoogle play

Last updated :

Also on site :



Latest News